Gay, and bisexual men changing sexual behavior to reduce risk of monkeypox

A study conducted by scientists from the US Centers for Disease Control and Prevention (CDC) indicates that reducing one-time sexual partnerships among gay, bisexual, and other men who have sex with men can significantly reduce the transmission of the monkeypox virus. The research is published in the CDC's Morbidity and Mortality Weekly Report (MMWR).

Study: Modeling the Impact of Sexual Networks in the Transmission of Monkeypox virus Among Gay, Bisexual, and Other Men Who Have Sex With Men — United States, 2022. Image Credit: NIAID

Study: Modeling the Impact of Sexual Networks in the Transmission of Monkeypox virus Among Gay, Bisexual, and Other Men Who Have Sex With Men — United States, 2022. Image Credit: NIAID

Background

Global outbreaks of monkeypox infections in 2022 have indicated that sexual contact is the primary route of monkeypox transmission among men with multiple male sex partners.

Some recent survey reports have revealed that men who have sex with men (MSM) have adopted certain measures to protect themselves and their partners from monkeypox infection. The most common measure is reducing one-time sexual partnerships.

Various models of sexual infection transmission developed by the CDC have previously been used to study the spread of human immunodeficiency virus (HIV) and gonorrhea in the US. In the current study, these models were used to study the transmission dynamics of monkeypox infection among MSM.

Study design

The dynamic network models simulated by CDC represent sexual behaviors between MSM. In these models, men were predicted to have various types of sexual relationships, including primary, causal, or one-time partnerships.

According to the model simulations, men might have zero or one primary sexual partnership at a time that lasted on average 477 days, or zero, one, or two casual partnerships at a time that lasted for on average 166 days. In addition, men might have one-time partnerships that lasted for one day.

Between 2016 and 2019, CDC collected data from MSM, who reported the number, type, and duration of their current sexual partnerships. This data was used to develop six categories of sexual activity, which differ in their rate of one-time partnership formation.

Two conditions of monkeypox transmission were simulated wherein ten highly active cases were introduced to a population of 10,000 MSM. Both lower and higher transmission rates were considered by adjusting transmission probability per act. In the lower transmission condition, monkeypox was assumed to infect 15% of MSM. In the higher transmission condition, the virus was expected to infect 25% of MSM.

The reduction in the percentage of infected MSM was estimated at baseline (time of viral entry in the population) and under a condition wherein MSM reduced the frequency of one-time partnerships by 40% after 2.5 months of viral entry in the population. This condition was created based on the observations made in recent surveys.

Modeled number* of new infections each day by lower† and higher§ transmission scenarios and type of partnership over the course of a monkeypox outbreak among men who have sex with men, by time since importation of 10 high activity cases — United States, 2022

Modeled number* of new infections each day by lower† and higher§ transmission scenarios and type of partnership over the course of a monkeypox outbreak among men who have sex with men, by time since importation of 10 high activity cases — United States, 2022

Important observations

The predictions made by the models revealed that MSM with more than one partner in the past three weeks have a 2 – 7 times higher risk of contracting monkeypox infection compared to those with only one partner. 

Considering the lower transmission condition, MSM in the highest category of sexual activity have a 3.6 times higher risk of contracting monkeypox infection compared to those with only one partner in the past three weeks. In the higher transmission condition, these men were predicted to have a 7 times higher risk of contracting the infection.

A disproportionate effect of one-time partnerships was observed on viral transmission. In the models, one-time partnerships represented 3% of the total daily partnerships and 16% of the sexual contacts on a given day. However, depending on the rate of transmission, these partnerships accounted for 46% to 54% of viral transmission.  

In the lower transmission condition, one-time, casual, and primary partnerships were associated with 54%, 33%, and 12% of viral transmission, respectively. In the higher transmission condition, about 45%, 38% and 15% of transmissions were caused by one-time, casual, and primary partnerships, respectively.

Notably, the model predicted that a 40% reduction in one-time partnerships could decrease the percentage of infected MSM by 20% to 31%. This effect was more significant in the lower transmission condition. Furthermore, the reduction in one-time partnerships delayed the timing of accumulating 10% infection by 150 days.

Study significance

This CDC study highlights the significance of reducing one-time partnerships in lowering the risk of monkeypox spread among MSM. Reducing the number of one-time or casual sex partners can substantially control monkeypox outbreaks in non-endemic countries.

The scientists suggest that the observed effect could be increased further by implementing additional control measures, such as vaccination, testing, and contact tracing.

Journal reference:
Dr. Sanchari Sinha Dutta

Written by

Dr. Sanchari Sinha Dutta

Dr. Sanchari Sinha Dutta is a science communicator who believes in spreading the power of science in every corner of the world. She has a Bachelor of Science (B.Sc.) degree and a Master's of Science (M.Sc.) in biology and human physiology. Following her Master's degree, Sanchari went on to study a Ph.D. in human physiology. She has authored more than 10 original research articles, all of which have been published in world renowned international journals.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dutta, Sanchari Sinha Dutta. (2022, August 29). Gay, and bisexual men changing sexual behavior to reduce risk of monkeypox. News-Medical. Retrieved on November 25, 2024 from https://www.news-medical.net/news/20220829/Gay-and-bisexual-men-changing-sexual-behavior-to-reduce-risk-of-monkeypox.aspx.

  • MLA

    Dutta, Sanchari Sinha Dutta. "Gay, and bisexual men changing sexual behavior to reduce risk of monkeypox". News-Medical. 25 November 2024. <https://www.news-medical.net/news/20220829/Gay-and-bisexual-men-changing-sexual-behavior-to-reduce-risk-of-monkeypox.aspx>.

  • Chicago

    Dutta, Sanchari Sinha Dutta. "Gay, and bisexual men changing sexual behavior to reduce risk of monkeypox". News-Medical. https://www.news-medical.net/news/20220829/Gay-and-bisexual-men-changing-sexual-behavior-to-reduce-risk-of-monkeypox.aspx. (accessed November 25, 2024).

  • Harvard

    Dutta, Sanchari Sinha Dutta. 2022. Gay, and bisexual men changing sexual behavior to reduce risk of monkeypox. News-Medical, viewed 25 November 2024, https://www.news-medical.net/news/20220829/Gay-and-bisexual-men-changing-sexual-behavior-to-reduce-risk-of-monkeypox.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
WHO lists first mpox in vitro diagnostic test under Emergency Use Listing